U.S. Homebuilding Expansion
A carefully selected group of companies positioned to benefit from America's strong housing market. These stocks span the entire construction value chain, from homebuilders to material suppliers and component manufacturers, all chosen by our expert analysts.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
About This Group of Stocks
Our Expert Thinking
The impressive decade-long growth of TopBuild signals a resilient U.S. housing market with long-term staying power. This collection taps into the economic ripple effects of strong housing demand, capturing value across the entire construction ecosystem from foundation to finishing touches.
What You Need to Know
This group offers diversified exposure to America's housing strength through various business models. These companies benefit from both new construction and the renovation of existing homes, providing balanced opportunities even as housing market conditions naturally fluctuate.
Why These Stocks
We've selected companies across the full homebuilding value chain to capture different aspects of market growth. From major homebuilders directly constructing properties to manufacturers of essential components like windows and decking, each company plays a vital role in meeting housing demand.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+34.92%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 34.92% over the next year.
Stocks Rated Buy by Analysts
7 of 14 assets in this group are rated Buy by professional analysts.
Group Growth vs Bank interest
This group averaged a 13.9% return last month, beating the typical 4% bank rate.
Why You'll Want to Watch These Stocks
America Needs More Homes
The U.S. faces a housing shortage of millions of units. These companies are positioned to fulfill this massive demand, potentially for years to come.
Double Market Opportunity
These stocks benefit from both new construction AND the renovation boom happening across America's aging housing stock, creating multiple revenue streams.
Essential Industry Leaders
This collection includes established market leaders who have proven their ability to thrive even through economic cycles, delivering both growth and stability.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.